November 19, 2020
Nordic Nanovector completes enrolment into second safety cohort of follicular lymphoma patients in Archer-1 Phase 1b Betalutin®/rituximab combination trial
Media
November 19, 2020
Nordic Nanovector ASA: Results for the Third Quarter 2020
November 18, 2020
Vivet Therapeutics and Pfizer Inc. Announce FDA Authorization to Proceed with GATEWAY, the Phase 1/2 Study for VTX-801, Vivet’s Investigational Gene Therapy for Wilson Disease
November 18, 2020
SPRUCE BIOSCIENCES REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
November 16, 2020
Vicore Pharma recruits the first patient in the phase II Proof-of-Concept study in idiopathic pulmonary fibrosis
November 13, 2020
InCarda Therapeutics Presents Positive New Data from Phase 2 Study of InRhythm™ in Patients with Paroxysmal Atrial Fibrillation at American Heart Association Scientific Sessions 2020
November 10, 2020
Fusion Pharmaceuticals Announces Third Quarter 2020 Financial Results And Business Update
November 10, 2020
Pulmonx Reports Third Quarter 2020 Financial Results
November 09, 2020
Targovax announces poster at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 06, 2020
Interim report July-September 2020
